secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2023-12-12T23:59:59+00:00
Accession:  0001193125-23-293373
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm receives Nasdaq deficiency notice for bid price below $1.00 per share
--------------------------------------------------------------------------------

- Received deficiency letter on Dec 6, 2023 for failing to meet Nasdaq's $1.00 minimum bid price rule for 30 consecutive business days.
- Has until June 3, 2024 to regain compliance by closing at $1.00+ for at least 10 consecutive business days.
- If non-compliant by June 3, may seek additional 180-day period by transferring to Nasdaq Capital Market and potentially effecting a reverse stock split.
- Company's common stock remains listed on Nasdaq Global Select Market during the 180-day compliance period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312523293373/0001193125-23-293373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312523293373/d647429d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-293373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer